• Main Menu
Main Menu
Menu

V. Bobby Bringi

V. Bobby Bringi

V. Bobby Bringi

Research Professor

Biography

Dr. V. Bobby Bringi serves as Research Professor at msu’s Department of Chemical Engineering & Materials Science. Dr. Bringi leads the team of developers working to commercialize afex—a disruptive technology that upgrades underutilized agricultural residues into high-quality cattle feed as well as a feedstock for biobased fuels and chemicals. The afex project is a collaborative partnership between msu, mbi, and other international institutions and agencies. Dr. Bringi was the co-founder of Phyton, a venture that developed and commercialized a groundbreaking route to the sustainable production of the anti-cancer drug, Taxol, in collaboration with Bristol Myers Squibb. He later served as ceo of mbi, presiding over its growth into a well-respected biotechnology hub that has been sought after by leading industry and academic innovators for derisking and scale-up services. He earned his doctorate from Cornell University in chemical engineering. In 2015, Bringi was elected as a Fellow of the American Institute for Medical and Biological Engineering.

Education
Ph.D, Chemical Engineering, Cornell University
MSU Scholars ID
venkataraman-bringi